pharma

Ryan Breslow has had a tumultuous 2022. It’s not slowing him down. Few outside of Breslow’s world even knew his name a year ago. Then Bolt, a “one-click” checkout tech company that evo

In the creation of a new drug, there comes a point where you have to finally put the molecule in a real creature — one at a time — and see if it actually does what you think it does. Manifold Bio&

SwipeRx, a platform for pharma professionals, said Tuesday it has secured a $27 million Series B round led by Indonesia’s MDI Ventures, with participation from the Gates Foundation, Johnson & Jo

The necessity of animal testing is a sad one for the process of drug discovery, but there’s seemingly no good alternative to mice, even though they’re not particularly accurate human analo

There’s a clear pain point when it comes to drug discovery: Depending on which study you cite, creating an approved drug costs anywhere from $985 million to $2.6 billion. And R&D returns have re

While economic conditions and the ongoing global coronavirus pandemic may not make for the best atmosphere for raising funding, some companies are still announcing round closures with significant mone

It was only a matter of time before healthcare providers would start prescribing mHealth apps as soon as they proved to be as or more effective than prescription drugs. Happtique, a mobile health appl

Index Ventures may be best known on these pages for its technology investments, but today it launched a new fund that points to how the company is willing to put its money into other examples of stron

A group of women is re-entering the workforce today and reshaping how products are made across key tech sectors like health & wellness, commerce and social products. Not only do they have the expe